Floatz logo

Therapeutic Asset Ratings

3,227 results matching 1 filter

91,565 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Metoclopramide
Obesity Disorder
Mater Misericordiae University HospitalP4B (57)
MT-5199
Major Depressive Disorder
Neurocrine BiosciencesP4B (57)
Naltrexone
Bipolar I Disorder
Mayo ClinicP4B (57)
Naltrexone
Bipolar II Disorder
Mayo ClinicP4B (57)
Naltrexone
Morbid Obesity
Laval UniversityP4B (57)
Nerve Growth Factor
Ischemic Stroke
The Third Affiliated hospital of Zhejiang Chinese Medical UniversityP4B (57)
Nintedanib
Small Cell Lung Carcinoma
The Affiliated Hospital of Qingdao UniversityP4B (57)
Normal Human Serum Albumin
Female Reproductive Organ Cancer
Joachim ZdolsekP4B (57)
Oxycodone
Morbid Obesity
University of California, DavisP4B (57)
Oxygen
Tinnitus
Jay C. Buckey Jr.P4B (57)
Panobinostat
Thalassemia
Novartis PharmaceuticalsP4B (57)
Peg-Rhg-Csf
Lymphoma
Ou Bai, MD/PHDP4B (57)
Plerixafor
Lymphoma
Peking UniversityP4B (57)
Progesterone
Psychotic Disorder
University of North Carolina, Chapel HillP4B (57)
Propofol
Gastric Cancer
RenJi HospitalP4B (57)
Prothrombin Complex Concentrate
Osteoarthritis, Hip
Konkuk University Medical CenterP4B (57)
Ropivacaine
Colorectal Cancer
Tri-Service General HospitalP4B (57)
Ropivacaine
Pancreatic Neoplasm
Institutul Regional de Gastroenterologie & Hepatologie Prof. dr. Octavian FodorP4B (57)
Safinamide Mesilate
Parkinson Disease
Eisai Korea Inc.P4B (57)
Sertraline
Cognitive Disorder
Fondazione IRCCS Ca' Granda, Ospedale Maggiore PoliclinicoP4B (57)
Sitagliptin
Parkinson Disease
Mayo ClinicP4B (57)
Spironolactone
Alzheimer Disease
Emory UniversityP4B (57)
Telmisartan
Stroke Disorder
Spaulding Rehabilitation HospitalP4B (57)
Trametinib
Glioblastoma
National Cancer Institute (NCI)P4B (57)
Varenicline
Parkinson Disease
Vikas KotagalP4B (57)
Showing 2876 to 2900 of 3,227 assets
PreviousPage 116 of 130Next